Module Database Search
MODULE DESCRIPTOR | |||
---|---|---|---|
Module Title | |||
Collaborative Working in Medicines Management | |||
Reference | PLM012 | Version | 1 |
Created | August 2022 | SCQF Level | SCQF 11 |
Approved | January 2023 | SCQF Points | 30 |
Amended | August 2021 | ECTS Points | 15 |
Aims of Module | |||
---|---|---|---|
To develop successful approaches to practice that ensure the safe, effective and efficient use of medicines through collaborative working. |
Learning Outcomes for Module | |
---|---|
On completion of this module, students are expected to be able to: | |
1 | Critically evaluate and reflect on the structures and processes required to ensure the provision of effective healthcare. |
2 | Systematically explore and evaluate the critical aspects that support continuity of care. |
3 | Critically reflect on team-working skills required for effective collaborative working. |
Indicative Module Content |
---|
Team-working skills, including leadership and management skills, to support effective collaborative working. Critical aspects that support continuity of care, including patient safety and medicines reconciliation, between health and social care settings. The structures and processes, including clinical governance and evidence based practice, required to achieve safe and effective medicines management. |
Module Delivery |
---|
Online delivery; self-directed learning supported by web-based learning materials, peer to peer learning, participation in synchronous and asynchronous webinars and discussion fora. |
Indicative Student Workload | Full Time | Part Time |
---|---|---|
Contact Hours | N/A | 10 |
Non-Contact Hours | N/A | 290 |
Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
TOTAL | N/A | 300 |
Actual Placement hours for professional, statutory or regulatory body |   |   |
ASSESSMENT PLAN | |||||
---|---|---|---|---|---|
If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
Component 1 | |||||
Type: | Practical Exam | Weighting: | 100% | Outcomes Assessed: | 1, 2, 3 |
Description: | An individual oral presentation. |
MODULE PERFORMANCE DESCRIPTOR | |
---|---|
Explanatory Text | |
Component 1 (oral presentation) comprises 100% of the module grade. A minimum of module grade D is required to pass the module. | |
Module Grade | Minimum Requirements to achieve Module Grade: |
A | A |
B | B |
C | C |
D | D |
E | E |
F | F |
NS | Non-submission of work by published deadline or non-attendance for examination |
Module Requirements | |
---|---|
Prerequisites for Module | None in addition to course entry requirements. |
Corequisites for module | None. |
Precluded Modules | None. |
INDICATIVE BIBLIOGRAPHY | |
---|---|
1 | JOINT FORMULARY COMMITTEE, 2022. British National Formulary. 84th edition. London: BMJ Group and Pharmaceutical Press. |